USPTO serial 97981644
CSL PLASMA
Reviewed by CopyMark Law Group
Status 819
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEVINE, HOWARD B
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CSL PLASMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Parkville, Victoria, AU
Parkville, Victoria, AU
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 THOMAS JEFFERSON ST, NW, SUITE 400WASHINGTON, DC 20007United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Promoting public awareness of blood diseases, illnesses and conditions; Promoting public awareness of blood plasma donation | ACTIVE | — |
| 042 | Medical Research; Scientific Research in the field of medicines; Scientific Research and Development in the field of medicines; research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceutical preparations for gene therapy; Scientific Research in the field of blood plasma and blood plasma donation; Research and Development services in the fields of medicine, healthcare, blood conditions, gene and cell therapy, biotherapies and vaccines; Scientific and technological research, namely, scientific testing and screening services, in the nature of testing of human blood plasma for safety and quality; research and development of medical products, pharmaceutical products and blood products; scientific testing and screening services, namely, testing of human blood plasma for safety and quality; medical laboratory services regarding human blood plasma | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 2, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Nov 2, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 5, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 5, 2026 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Oct 5, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Sep 28, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 20, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Aug 20, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 19, 2026 | IUAF | USE AMENDMENT FILED | — |
| Aug 19, 2026 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Aug 19, 2026 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Aug 19, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jan 30, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 27, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jan 27, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jan 27, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 28, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 28, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 28, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 28, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 4, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 27, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 27, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 27, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 29, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 29, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 29, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 29, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 27, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 2, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 2, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 13, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 28, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 28, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 28, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 28, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 28, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 26, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 25, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 25, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 26, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 26, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 26, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 19, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 20, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 7, 2022 | NWAP | NEW APPLICATION ENTERED | — |